Clinical trial
Evaluating the Effectiveness of Intramuscular Versus Intravenous Tranexamic Acid for Minimizing Blood Loss After Total Hip Arthroplasty: A Randomized Controlled Trial
NCT07817537 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Effectiveness of Intramuscular Versus Intravenous Tranexamic Acid for Minimizing Blood Loss After Total Hip Arthroplasty: A Randomized Controlled Trial
- Lead sponsor
- Alexandria University
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- January 15, 2026
- Completion date
- March 1, 2027
- Enrollment
- 128 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood loss after a total hip replacement